These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12417449)

  • 21. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
    Wens I; Keytsman C; Deckx N; Cools N; Dalgas U; Eijnde BO
    Eur J Neurol; 2016 Jun; 23(6):1028-35. PubMed ID: 26992038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
    Frota ER; Rodrigues DH; Donadi EA; Brum DG; Maciel DR; Teixeira AL
    Neurosci Lett; 2009 Aug; 460(2):130-2. PubMed ID: 19477225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
    Lindquist S; Hassinger S; Lindquist JA; Sailer M
    Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
    Tongiorgi E; Sartori A; Baj G; Bratina A; Di Cola F; Zorzon M; Pizzolato G
    J Neurol Sci; 2012 Sep; 320(1-2):161-5. PubMed ID: 22836016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Clin Immunol; 2006 Jan; 118(1):77-82. PubMed ID: 16275091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression Analysis of BDNF Gene and BDNF-AS Long Noncoding RNA in Whole Blood Samples of Multiple Sclerosis Patients: Not Always a Negative Correlation between Them.
    Gharzi V; Gangi M; Sayad A; Mazdeh M; Arsang-Jang S; Taheri M
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):548-556. PubMed ID: 30644699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.
    Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P
    Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis.
    Whitaker JN; Wolinsky JS; Narayana PA; Bartolucci AA; Noseworthy JH; Lublin FD; Linde A; Gjörstrup P; Sullivan HC;
    Arch Neurol; 2001 Jan; 58(1):49-54. PubMed ID: 11176936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
    Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.
    Azoulay D; Vachapova V; Shihman B; Miler A; Karni A
    J Neuroimmunol; 2005 Oct; 167(1-2):215-8. PubMed ID: 16083971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis.
    Rezaei N; Amirghofran Z; Nikseresht A; Ashjazade N; Zoghi S; Tahvili S; Kamali-Sarvestani E
    Immunol Invest; 2016 Oct; 45(7):679-91. PubMed ID: 27611715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis.
    Yoshimura S; Ochi H; Isobe N; Matsushita T; Motomura K; Matsuoka T; Minohara M; Kira J
    Mult Scler; 2010 Oct; 16(10):1178-88. PubMed ID: 20656764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotropic drugs on in vitro brain-derived neurotrophic factor production in whole blood cell cultures from healthy subjects.
    Lee BH; Myint AM; Kim YK
    J Clin Psychopharmacol; 2010 Oct; 30(5):623-7. PubMed ID: 20814321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study.
    Yalachkov Y; Anschütz V; Maiworm M; Jakob J; Schaller-Paule MA; Schäfer JH; Reiländer A; Friedauer L; Behrens M; Steffen F; Bittner S; Foerch C
    Mult Scler Relat Disord; 2023 Mar; 71():104567. PubMed ID: 36805176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute exercise modulates BDNF and pro-BDNF protein content in immune cells.
    Brunelli A; Dimauro I; Sgrò P; Emerenziani GP; Magi F; Baldari C; Guidetti L; Di Luigi L; Parisi P; Caporossi D
    Med Sci Sports Exerc; 2012 Oct; 44(10):1871-80. PubMed ID: 22543740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T H1, relapsing-remitting course with enhanced T H0 reactivity.
    Barth H; Klein K; Börtlein A; Guseo A; Berg PA; Wiethölter H; Klein R
    J Neuroimmunol; 2002 Dec; 133(1-2):175-83. PubMed ID: 12446020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
    Cristofanilli M; Cymring B; Lu A; Rosenthal H; Sadiq SA
    Neuroscience; 2013 Oct; 250():614-21. PubMed ID: 23876320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.